title: A malignant, stem cell-like somatic hybrid between a mouse teratocarcinoma and a rat ascitic hepatoma is differentiation competent.
abstract: A hybrid clone was developed by the fusion of a pluripotent mouse teratocarcinoma cell line PCC-4 AzaR to the Zajdela ascitic hepatoma (ZAH) of rat origin. This hybrid cell line, F2231A, possessed a predominantly teratocarcinoma morphology with a large nucleus and prominent nucleoli, and grew in nests. F2231A cells formed undifferentiated tumours in irradiated Sv/129 mice. It formed aggregates when subcultured at high densities in bacteriological Petri dishes. The hybrid cell line differentiated in response to retinoic acid and also underwent spontaneous differentiation upon overgrowth. Karyological analysis showed the presence of several rat chromosomes in the hybrid and upon isozyme analysis it was found that only the rat variant of the X-linked enzyme HGPRT was expressed. Analysis of the genomic DNA with a cloned probe, specific for rat repetitive sequences, gave strong positive signals in the hepatoma parent and F2231A cells while the parental embryonal carcinoma (EC) cells were negative. The hybrid cell line, like the PCC-4 cells, expressed the SSEA-1 surface marker but not SSEA-3, intercellular fibronectin and EGF receptors. Upon differentiation of F2231A cells there was a loss of expression of SSEA-1. The mRNA for alpha-fetoprotein was expressed by the hybrid cell line and in this respect it resembled the hepatoma parent. Albumin mRNA was not detectable in the hybrid cell line. The mRNA for the transformation-related protein, p53, was expressed at a high level in F2231A cells. The hybrid cell line F2231A retained several of the biochemical and immunological properties of the teratocarcinoma cells.
authors: Centre for Cellular and Molecular Biology, RRL Campus, Hyderabad, India.
authors: V
authors: V
authors: Subramanian
mesh_terms: D000818:Animals; D000954:Antigens, Surface / Q000032:analysis; D015139:Blotting, Southern; D002454:Cell Differentiation / Q000187:drug effects; D004273:DNA, Neoplasm / Q000302:isolation & purification; D004815:Epidermal Growth Factor / Q000378:metabolism; D006822:Hybrid Cells / Q000166:cytology*; D007527:Isoenzymes; D007621:Karyotyping; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D008114:Liver Neoplasms, Experimental / Q000473:pathology*; D051379:Mice; D008970:Molecular Weight; D010641:Phenotype; D012313:RNA / Q000235:genetics / Q000302:isolation & purification; D051381:Rats; D012091:Repetitive Sequences, Nucleic Acid; D013234:Stem Cells / Q000166:cytology*; D013724:Teratoma / Q000473:pathology*; D014212:Tretinoin / Q000494:pharmacology; D014407:Tumor Cells, Cultured
chemical_list: D000954:Antigens, Surface; D004273:DNA, Neoplasm; D007527:Isoenzymes; D014212:Tretinoin; D004815:Epidermal Growth Factor; D012313:RNA; D007770:L-Lactate Dehydrogenase